Dr iur Dieter Gericke > Homburger > Zurich, Switzerland > Lawyer Profile

Dieter Gericke spearheads the ‘very skilled, professional and reliable’ team at Homburger, which is capable of acting for a host of blue-chip clients, with established prowess in regulated sectors such as banking and insurance, life sciences, nutrition and telecoms. The team demonstrates expertise across a variety of complex transactions, including venture capital, private equity, public M&A and auctions. Frank Gerhard focuses on M&A within the chemical and life sciences sectors. David Oser and Daniel Hasler demonstrate vast capabilities in private equity matter, while Daniel Daeniker is well regarded for his expertise in corporate governance. Andreas Müller is well equipped to advise on corporate and securities law, among other issues. Anna Peter, who was promoted to partner in January 2024, is also recommended.

Counting a number of key players in the Swiss capital market in its client roster, Homburger is noted for its expertise advising clients on tax and regulatory aspects of capital markets transactions. Frank Gerhard and Benjamin Leisinger co-lead the practice, with the former possessing considerable expertise in IPO, private placements and innovative structures. Benedikt Maurenbrecher’s capabilities encompass regulatory capital instruments, debt, and asset-based and equity-linked transactions. Dieter Gericke and Daniel Daeniker are both particularly active within the life sciences sector, while René Bösch is routinely entrusted by clients to handle debt capital market transactions. Daniel Häusermann bolsters the practice with his broad practice, and Lee Saladino’s strengths lie in regulatory capital and other debt instruments.

The Zurich based group at Homburger assists a diverse client base of well-known international pharma and healthcare giants, notably including Novartis, Sandoz, and Sanofi Aventis. The team displays deep bench strength across a variety of areas, including patent enforcement actions against generics producers, and joint ventures. Practice co-head Dieter Gericke has longstanding expertise in transactional matters, including public takeovers, shareholder activism, and public M&A. Co-head Andri Hess regularly acts in IP disputes and arbitrations, whilst maintaining a strong focus on pharma regulatory issues and IT. Co-head Richard Stäuber is known for his vast knowledge of Swiss and European competition issues, acting for clients in merger control proceedings, distribution arrangements, and investigations.